A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

Clinical trial NCT01205438 · COMPLETED

Trial details

NCT number: NCT01205438
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Connective Tissue Disease Autoimmune Disease

Start date: 2011-01-01
Primary completion: 2014-08-01
Enrollment: 1124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.